v3.26.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Cash flow from operating activities:    
Net loss $ (10,509) $ (10,330)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 212 258
Stock-based compensation expense 1,040 850
Issuance of common stock to vendor 1,258 253
Right-of-use asset amortization 205 268
(Loss) / gain on foreign currency transactions (2,552) 647
Change in fair value of the warrant liability   (672)
Debt discount amortization 87  
Change in operating assets and liabilities:    
Accounts receivable (3) 269
Research and development tax credit receivable (29) 84
Prepaid expenses and other assets 268 (33)
Accounts payable and accrued expenses 2,811 504
Lease liabilities (182) (281)
Other current liabilities (342) 87
Net cash used in operating activities (7,736) (8,096)
Cash flows from investing activities:    
Purchases of property, plant and equipment (123) (75)
Net cash used by investing activities (123) (75)
Cash flow from financing activities:    
Payment of issuance costs   (1,142)
Proceeds from the issuance of debt 1,000  
Proceeds from the exercise of warrants   24
Net cash provided by financing activities 1,000 6,532
Effect of exchange rate changes on cash 92 (56)
Net change in cash (6,767) (1,695)
Cash, beginning of period 7,141 8,836
Cash, end of period 374 7,141
Supplemental disclosure of cash and non-cash investing and financing activities    
Right-of-use asset and lease liability additions 708 82
Cash paid for income taxes $ (24) 1
Private placement    
Cash flow from financing activities:    
Proceeds from the issuance of common stock and warrants   3,300
Public placement    
Cash flow from financing activities:    
Proceeds from the issuance of common stock and warrants   $ 4,350

Source

HTML PDF
ZIP